Below is the latest update for LEGX that was posted on Facebook back in August. It can be fustrating at times with any little OTC company and the lack of updates and news. I wonder if the CEO has been asked to be MIA until something has been completed? As with most negotiating everyone is usually under a non disclosure while everyone does their due diligence and decide path to take?
LegacyXChange, Inc. Update
August 17, 2016
Due to a lack of financial resources, LegacyXChange, Inc. (the “Company”, “we”, “us” or “our”): (a) has been unable to complete and file its Form 10-K for its March 31, 2016 fiscal year end; (b) will be late with its Form 10-Q for the period ending June 30, 2016; and (c) has been unable to execute upon certain matters in its business plan, including attending the Cooperstown event that had been previously announced in the Company’s April 14, 2016 press release, although all of the items signed at the event can be marked with DNA at a later time prior to selling.
The Company has been negotiating with a technology development company that has significant experience bringing to market platforms dedicated for business to consumer activity. We have been sharing our current technology development with this company, which includes our business model, the site’s operation throughout the platform and the design and graphics required for the site. Pending an executed agreement, the terms of which are currently under negotiation, the technology company would provide the site development, ongoing site maintenance and provide the servers necessary to run the site, for a specified period and at such time the site would be deemed operational.
Forward Looking Statements and Disclaimer
Statements made in this company update express the Company’s intentions, plans, beliefs, expectations or predictions of future events, are forward-looking statements. The words "believe," "expect," "intend," "estimate," "anticipate," "will" and similar expressions are intended to further identify such forward-looking statements, although not all forward-looking statements contain these identifying words. Those statements are based on many assumptions and are subject to many known and unknown risks, uncertainties and other factors that could cause the Company's actual activities, results or performance to differ materially from those anticipated or projected in such forward-looking statements. For a discussion of these risks, see the Company's Form S-1, which may be reviewed at http://www.sec.gov
. In addition, you should review the Company's periodic reports also that are available at http://www.sec.gov
. The Company cannot guarantee future financial results; levels of activity, performance or achievements and investors should not place undue reliance on the Company's forward-looking statements. No information contained in this press release should be construed as any indication whatsoever of the Company's future financial performance, future revenues or its future stock price. With respect to the potential technology agreement, there are no assurances whatsoever that it will result in a fully executed agreement. The forward-looking statements contained herein represent the judgment of the Company as of the date of this press release. The Company expressly disclaims any intent, obligation or undertaking to update or revise such forward-looking statements to reflect any change in the Company's business with regard thereto or any change in events, conditions or circumstances on which any such statements are based.